Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sorakij Bhakeecheep
Observed names:
Bhakeecheep, Sorakij,
S Bhakeecheep,
Sorakij Bhakeecheep
Institution:
University of Phayao
Observed institutions:
Thai Red Cross Society,
Chulalongkorn University,
University of Phayao,
HIV Netherlands Australia Thailand Research Collaboration
OpenAlex ID:
A5034465202
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand
2015
·
Weerawat Manosuthi
, Sumet Ongwandee
, et al.
·
AIDS Research and Therapy
·
97
PDF
Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010
2010
·
Somnuek Sungkanuparph
, Wichai Techasathit
, et al.
·
Asian Biomedicine
·
89
PDF
Revisiting the Role of Neutralizing Antibodies in Mother‐to‐Child Transmission of HIV‐1
2006
·
Francis Barin
, Gonzague Jourdain
, et al.
·
The Journal of Infectious Diseases
·
55
A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study
2012
·
Torsak Bunupuradah
, Ploenchan Chetchotisakd
, et al.
·
Antiviral Therapy
·
51
PDF
Life Expectancy after Initiation of Combination Antiretroviral Therapy in Thailand
2016
·
Sirinya Teeraananchai
, Suchada Chaivooth
, et al.
·
Antiviral Therapy
·
32
Etravirine and Rilpivirine Resistance in HIV-1 Subtype Crf01_Ae-Infected Adults Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens
2011
·
Torsak Bunupuradah
, Jintanat Ananworanich
, et al.
·
Antiviral Therapy
·
28
Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial
2016
·
Torsak Bunupuradah
, Sasisopin Kiertiburanakul
, et al.
·
The Lancet HIV
·
27
The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014
2017
·
Suchada Chaivooth
, Sorakij Bhakeecheep
, et al.
·
Journal of Virus Eradication
·
23
PDF
Thai national guidelines for the use of antiretroviral therapy in pediatric HIV infection in 2010
2010
·
Thanyawee Puthanakit
, Auchara Tangsathapornpong
, et al.
·
Asian Biomedicine
·
21
PDF
Uptake of early infant diagnosis in Thailand’s national program for preventing mother‐to‐child HIV transmission and linkage to care, 2008–2011
2016
·
Thananda Naiwatanakul
, Nipunporn Voramongkol
, et al.
·
Journal of the International AIDS Society
·
19
PDF
Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings
2019
·
Ninutcha Paengsai
, Gonzague Jourdain
, et al.
·
Open Forum Infectious Diseases
·
18
PDF
Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study
2018
·
Ninutcha Paengsai
, Gonzague Jourdain
, et al.
·
BMC Public Health
·
18
PDF
Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy
2012
·
On behalf of the HIV STAR Study Group
, Torsak Bunupuradah
, et al.
·
Journal of NeuroVirology
·
16
Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program
2019
·
Sirinya Teeraananchai
, Thanyawee Puthanakit
, et al.
·
Journal of Virus Eradication
·
15
PDF
Loss to follow-up and Associated Factors of Patients in the National AIDS Program in Thailand
2017
·
Sirinya Teeraananchai
, Stephen J Kerr
, et al.
·
Antiviral Therapy
·
10
First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand
2017
·
Sirinya Teeraananchai
, Torsak Bunupuradah
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
7
Evolution of Interventions to Prevent Mother- To-Child Transmission of HIV: Perspective from Thailand
2020
·
Nittaya Phanuphak
, Kulkanya Chokephaibulkit
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
3
Second line lopinavir/ritonavir monotherapy was inferior to tenofovir/lamivudine/lopinavir/ritonavir in patients who failed NNRTI-regimen: HIV STAR study
2011
·
Torsak Bunupuradah
, Ploenchan Chetchotisakd
, et al.
·
F1000Research
·
3
Chronic Kidney Disease in a Large National Human Immunodeficiency Virus Treatment Program
2022
·
Ninutcha Paengsai
, Kajohnsak Noppakun
, et al.
·
Healthcare
·
2
PDF
Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program.
2017
·
Cheewanan Lertpiriyasuwat
, Achara Teeraratkul
, et al.
·
PubMed
·
2
Long term oral anticoagulant therapy after heart valve prostheses at Siriraj Hospital.
1989
·
P Talalak
, S Bhakeecheep
, et al.
·
PubMed
·
2
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz‐Based Regimens
2016
·
Nontiya Homkham
, Tim R. Cressey
, et al.
·
The Journal of Clinical Pharmacology
·
1
Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg in virologic suppressed HIV-infected Thai adults: a multicentre, randomized, open-label trial: LASA
2015
·
Torsak Bunupuradah
, Sasisopin Kiertiburanakul
, et al.
·
Journal of the International AIDS Society
·
1
A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study
2012
·
Torsak Bunupuradah
, Ploenchan Chetchotisakd
, et al.
·
Antiviral Therapy
·
1
Additional file 1: of Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study
2018
·
Ninutcha Paengsai
, Jourdain, Gonzague
, et al.
·
Figshare
Show more works
View as search
Works count:
27
Citation count:
541
H-index:
14
I10-index:
15
Year
Topic
Type
